Position in DXCM
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$67
-$749 QoQ
Shares Held
1
-92.3% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#962
of 966 holders
Holding Since
Mar 2022
8 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in DXCM Over Time
Shares Held
Position Value (USD)
Position in Medical Devices
Healthcare · as of Jun 30, 2026Elequin Capital, LP holds $2,284,726 across 11 Medical Devices names. DXCM ranks #10 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | BRKR |
Bruker Corp
|
4,783 | $2,142,353 | |
| 2 | BIO |
Bio-Rad Laboratories, Inc.
|
217 | $63,713 | |
| 3 | GMED |
Globus Medical Inc
|
493 | $38,951 | |
| 4 | MDT |
Medtronic plc
|
307 | $24,016 | |
| 5 | GEHC |
GE HealthCare Technologies Inc.
|
187 | $11,969 | |
| 6 | LIVN |
LivaNova PLC
|
28 | $2,302 | |
| 7 | TNDM |
Tandem Diabetes Care Inc
|
67 | $1,011 | |
| 8 | HAE |
Haemonetics Corp
|
2 | $150 |
All Filings in DXCM
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $67 | 1 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $816 | 13 | Shares | Sole | 2026-05-11 | |
| 2025-12-31 | $3,318 | 50 | Shares | Sole | 2026-02-17 | |
| 2024-12-31 | $9,954 | 128 | Shares | Sole | 2025-02-18 | |
| 2024-09-30 | $5,832 | 87 | Shares | Sole | 2024-11-14 | |
| 2024-03-31 | $42,442 | 306 | Shares | Sole | 2025-03-11 | |
| 2022-06-30 | $94,056 | 1,262 | Shares | Sole | 2022-08-11 | |
| 2022-03-31 | $157,572 | 308 | Shares | Sole | 2022-05-16 | |
| No filing history on record for this holder in this stock. | ||||||